NEW YORK (GenomeWeb News) – Protein biomarker technology firm Decision Biomarkers has closed up shop and filed for Chapter 7 bankruptcy.

Decision, based in Waltham, Mass., filed for bankruptcy on Dec. 22 in US Bankruptcy Court in Boston. Decision's website indicates that the company had closed its doors as of Dec. 2, 2009.

"There are several companies interested in the technology and we are hopeful the business will be reconstituted in the near future," Decision said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.